Literature DB >> 11416886

Carbamoylation of glomerular and tubular proteins in patients with kidney failure: a potential mechanism of ongoing renal damage.

L M Kraus1, L Gaber, C R Handorf, H P Marti, A P Kraus.   

Abstract

BACKGROUND: Cyanate formed spontaneously from urea carbamoylates non-protonated amino groups of protein, irreversibly altering function, charge and structure. Carbamoylated proteins in renal tissue have not been examined hitherto.
OBJECTIVES: To identify homocitrulline (epsilon-amino-carbamoyl-lysine), a result of in vivo carbamoylation by urea-derived cyanate, from patients with renal disease or in newly transplanted kidneys by immunohistochemistry. To evaluate enzymatic activity of carbamoylated and non-carbamoylated matrix metalloproteinase-2 and correlate this with renal tissue carbamoylated in vivo.
DESIGN: Anti-homocitrulline antibody is specific for homocitrulline and was used to identify carbamoylation of epsilon-amino-lysine in renal biopsies from patients with elevated BUN, with isolated proteinuria, and as controls, from normal donors at time of transplantation. Enzymatic activity of matrix metalloproteinase-2 carbamoylated in vitro was evaluated.
RESULTS: Homocitrulline was present in glomerular basement membrane (8/10), mesangium (8/10), tubular epithelium and cytoplasm (7/10) and Bowman's capsule (1/10) in patients with elevated BUN. The discordant patterns of glomerular and tubular localization of homocitrulline versus immune complexes indicated that the carbamoylated proteins were not a component of immune deposits but were modified proteins in renal tissue. No homocitrulline was found in transplanted kidneys (14/15) or in proteinuric patients (2/2). Enzymatic activity of both human and rat matrix metalloproteinase-2 was strongly inhibited in a dose-dependent fashion when incubated with cyanate.
CONCLUSIONS: In situ carbamoylation in proteins occurred in kidneys of patients with renal dysfunction but not in normal newly transplanted kidneys. Decreased enzymatic activity of carbamoylated enzymes may alter specific renal regulatory mechanisms. Carbamoylated proteins with altered function and charge may represent a previously underestimated mechanism in renal pathophysiology.

Entities:  

Mesh:

Substances:

Year:  2001        PMID: 11416886     DOI: 2001/11/smw-09691

Source DB:  PubMed          Journal:  Swiss Med Wkly        ISSN: 0036-7672            Impact factor:   2.193


  11 in total

1.  Carbamylation-dependent activation of T cells: a novel mechanism in the pathogenesis of autoimmune arthritis.

Authors:  Piotr Mydel; Zeneng Wang; Mikael Brisslert; Annelie Hellvard; Leif E Dahlberg; Stanley L Hazen; Maria Bokarewa
Journal:  J Immunol       Date:  2010-05-19       Impact factor: 5.422

2.  Carbamylation of Integrin α IIb β 3: The Mechanistic Link to Platelet Dysfunction in ESKD.

Authors:  Veronika Binder; Barbara Chruścicka-Smaga; Brith Bergum; Stéphane Jaisson; Philippe Gillery; Joar Sivertsen; Tor Hervig; Marta Kaminska; Ronak Tilvawala; Venkatesh V Nemmara; Paul R Thompson; Jan Potempa; Hans-Peter Marti; Piotr Mydel
Journal:  J Am Soc Nephrol       Date:  2022-08-29       Impact factor: 14.978

Review 3.  Avenues for post-translational protein modification prevention and therapy.

Authors:  Mengyao Tang; Sahir Kalim
Journal:  Mol Aspects Med       Date:  2022-02-25

4.  Characterization of the Pseudomonas pseudoalcaligenes CECT5344 Cyanase, an enzyme that is not essential for cyanide assimilation.

Authors:  Víctor M Luque-Almagro; María-J Huertas; Lara P Sáez; Manuel Martínez Luque-Romero; Conrado Moreno-Vivián; Francisco Castillo; M Dolores Roldán; Rafael Blasco
Journal:  Appl Environ Microbiol       Date:  2008-08-15       Impact factor: 4.792

5.  Protein carbamylation and chronic kidney disease progression in the Chronic Renal Insufficiency Cohort Study.

Authors:  Sahir Kalim; Anders H Berg; Subbian Ananth Karumanchi; Ravi Thadhani; Andrew S Allegretti; Sagar Nigwekar; Sophia Zhao; Anand Srivastava; Dominic Raj; Rajat Deo; Anne Frydrych; Jing Chen; James Sondheimer; Tariq Shafi; Matthew Weir; James P Lash
Journal:  Nephrol Dial Transplant       Date:  2021-12-31       Impact factor: 7.186

Review 6.  Autoantibodies to posttranslational modifications in rheumatoid arthritis.

Authors:  Agata N Burska; Laura Hunt; Marjorie Boissinot; Rocky Strollo; Brent J Ryan; Ed Vital; Ahuva Nissim; Paul G Winyard; Paul Emery; Frederique Ponchel
Journal:  Mediators Inflamm       Date:  2014-03-23       Impact factor: 4.711

7.  Metabolic Differences between Dogs of Different Body Sizes.

Authors:  Rondo P Middleton; Sebastien Lacroix; Marie-Pier Scott-Boyer; Nikola Dordevic; Adam D Kennedy; Amanda R Slusky; Jerome Carayol; Christina Petzinger-Germain; Alison Beloshapka; Jim Kaput
Journal:  J Nutr Metab       Date:  2017-10-26

8.  Proteasome-dependent degradation of intracellular carbamylated proteins.

Authors:  Aurore Desmons; Anaïs Okwieka; Manon Doué; Laëtitia Gorisse; Vincent Vuiblet; Christine Pietrement; Philippe Gillery; Stéphane Jaisson
Journal:  Aging (Albany NY)       Date:  2019-06-06       Impact factor: 5.682

9.  Chronic increase of urea leads to carbamylated proteins accumulation in tissues in a mouse model of CKD.

Authors:  Christine Pietrement; Laëtitia Gorisse; Stéphane Jaisson; Philippe Gillery
Journal:  PLoS One       Date:  2013-12-04       Impact factor: 3.240

10.  Metabolomics approach reveals effects of antihypertensives and lipid-lowering drugs on the human metabolism.

Authors:  Elisabeth Altmaier; Gisela Fobo; Margit Heier; Barbara Thorand; Christine Meisinger; Werner Römisch-Margl; Melanie Waldenberger; Christian Gieger; Thomas Illig; Jerzy Adamski; Karsten Suhre; Gabi Kastenmüller
Journal:  Eur J Epidemiol       Date:  2014-05-10       Impact factor: 8.082

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.